Diphtheria, tetanus, acellular pertussis and hepatitis B recombinant, adsorbed vaccine (GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDiphtheria, tetanus, acellular pertussis and hepatitis B recombinant, adsorbed vaccine (GlaxoSmithKline)
Drug Alias Name白喉，破伤风，百日咳和乙肝吸附疫苗Infanrix HepB
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Toxoid vaccineVaccines > Vaccine type > Combination vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BTetanusDiphtheria +[4] 
Global Approved IndicationsHepatitis BTetanusDiphtheria +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date1997/07/30
Country/TerritoryEU
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Biologicals SA
Active IndicationsN/A
Inactive IndicationsHepatitis BTetanusDiphtheria +[4] 

Other Information

ATC CodeJ07CA05
Related LinksN/A